Covid-19 roundup: In­vestors call to link CEO salaries to vac­cine ac­cess; Why there aren't more ini­tial sup­plies of the Pfiz­er pill

A group of in­sti­tu­tion­al in­vestors from No­mu­ra, BMO, GAM and more than 60 oth­ers rep­re­sent­ing tril­lions in as­sets are now call­ing on Covid-19 vac­cine de­vel­op­ers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER